cardiovascular medications | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19,033 results for “cardiovascular medications”

Trials

View all 13010 →

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

2,004 participants · First posted Jan 27, 2010

Synchronization to Improve Non-Adherence to Cardiovascular Medications

3,675 participants · First posted Oct 16, 2013

The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians

660 participants · First posted Sep 30, 2008

Drugs

View all 125 →

cardiovascular program

cardiovascular therapeutics (MIGENIX)

Anti-Aging Medications(Chengdu WestGene Biopharma )

Organizations

View all 121 →

CONTROLLED MEDICATIONS LIMITED

Hong Kong, China

Reprieve Cardiovascular, Inc.

United States

CARDIOVASCULAR RESEARCH FOUNDATION

United States

News

View all 5777 →

Global Study Reveals Critical Underutilization of Secondary Prevention Medications for Cardiovascular Disease

ADHD Medications Show Minimal Cardiovascular Effects in Comprehensive Analysis

American Heart Association Awards $1M to Study GLP-1 Medications' Impact on Cardiovascular Risk

Page 1 of 1904